wellrank.ai
Sign In
Sequence logo

Sequence

First cited by AI Jun 11, 2026
sequencewiz.org

Surfaced organically in AI answers about glp-1 weight loss. Not yet profiled.

AI Visibility

Visibility trend

Zepbound, daily share of AI answers mentioning Sequence, through Sep 12, 2026.

15.6%

Avg position when mentioned: 3.7 · peak 18% on Sep 9

By engine

Where Sequence is strong, and where it is invisible.

  • Google AI
    26.7%
  • Claude
    20.0%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 326 positive mentions
  • 120 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Sequence

ClaudeSep 12, 2026, 14:26 UTC
Where can I start tirzepatide treatment online this week?

Online Tirzepatide Treatment Options Here are some reputable telehealth platforms where you can typically get started quickly: Well-Known Providers Hims & Hers - Large platform, quick intake process, offers compounded tirzepatide Ro (Body) - Straightforward online assessment, medical team reviews promptly LifeMD - Offers telehealth visits with licensed providers Sequence (WeightWatchers) - Combines medication with behavioral support Noom Med - Pairs medication with their coaching program What to Expect Online health questionnaire Virtual consultation with a licensed provider Prescription sent to pharmacy if approved Brand name Zepbound (FDA-approved for weight loss) or compounded versions available Important Notes ⚠️ Requires medical evaluation - not everyone qualifies Typical qualifiers: BMI ≥30, or ≥27 with weight-related condition Costs vary widely ($200-$1,000+/month depending on brand vs. compounded) Insurance coverage is limited but possible Fastest Option Hims & Hers or Ro typically have the quickest onboarding if speed is your priority. Would you like more details on cost or what the process involves?

Mentioned in position 4 of 5

Read full answer with sources →
ClaudeSep 11, 2026, 15:19 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

Compounded GLP-1 Providers Using Licensed US Pharmacies Here are some well-known providers that work with FDA-registered, state-licensed US compounding pharmacies: Telehealth + Pharmacy Partners Hims & Hers – Uses licensed compounding pharmacies; offers semaglutide compounds with physician oversight Ro (Body Program) – Partners with 503B outsourcing facilities, which have higher FDA oversight standards Mochi Health – Works with licensed US compounding pharmacies; focuses on obesity medicine LifeMD / RexMD – Uses licensed US pharmacies for compounded semaglutide Sequence (now WeightWatchers Clinic) – Connects patients with licensed prescribers and pharmacies Important Distinctions to Know 503A pharmacies – Patient-specific compounding, licensed by states 503B outsourcing facilities – Higher FDA oversight, can produce larger batches; generally considered the gold standard for safety Tips When Choosing Ask specifically if they use a 503B facility Verify the pharmacy's license through your state board of pharmacy Confirm the active ingredient is semaglutide or tirzepatide (not just "peptides") ⚠️ Note: The FDA has raised concerns about some compounded GLP-1s. Always verify current regulations, as the landscape changes frequently. Want more detail on any specific provider?

Mentioned in position 6 of 7

Read full answer with sources →
ClaudeSep 11, 2026, 15:18 UTC
Does any telehealth service help get Wegovy covered by insurance?

Telehealth Services for Wegovy Insurance Coverage Yes, several telehealth platforms specifically help navigate insurance coverage for Wegovy: Strong Options Ro Body Has a dedicated insurance concierge team that works to get GLP-1s covered Helps with prior authorizations and appeals Transparent about coverage likelihood upfront Calibrate Built their entire model around working with insurance Assigns a care team that handles prior authorization paperwork Focuses on metabolic health with lifestyle coaching included Found Works with insurance and has staff to help with prior auth Offers multiple medication options depending on coverage Sequence (now part of WW) Specifically designed around GLP-1 medications and insurance navigation Providers experienced with writing prior authorizations What to Know Prior authorization is the key hurdle - you typically need to document a BMI ≥30 or ≥27 with a weight-related condition No service can guarantee coverage - that depends on your specific plan Many employer plans still exclude GLP-1s for weight loss entirely Tip Check your insurance's formulary first, then choose a telehealth service that specializes in prior authorization support rather than just prescribing. Would you like more detail on any of these?

Mentioned in position 4 of 5

Read full answer with sources →
ClaudeSep 11, 2026, 15:18 UTC
What are the best alternatives if I cannot get Ozempic, and who prescribes them online?

Best Ozempic Alternatives & Online Prescribers Similar GLP-1 Medications Wegovy (semaglutide) Same active ingredient as Ozempic but FDA-approved specifically for weight loss Higher doses available Often covered by insurance for obesity Mounjaro/Zepbound (tirzepatide) Dual GIP/GLP-1 receptor agonist - often considered more effective than semaglutide Zepbound is the weight-loss approved version Saxenda (liraglutide) Older GLP-1, injected daily vs. weekly More widely available currently Victoza (liraglutide) Diabetes-focused version of Saxenda Reputable Online Prescribers Service Notes Hims/Hers Offers compounded semaglutide Ro Body Prescribes GLP-1s with ongoing support Found Combines medication + coaching Sequence (WeightWatchers) Connects to prescribers, insurance navigation help Noom Med Integrated with Noom program Important Notes Compounded semaglutide is widely available but has less FDA oversight Always verify prescribers are licensed in your state Discuss your full medical history honestly Costs vary widely - check insurance coverage first Would you like more detail on any specific option?

Mentioned in position 4 of 5

Read full answer with sources →
ClaudeSep 10, 2026, 15:14 UTC
I have a BMI of 31. Do I qualify for Wegovy and who can prescribe it online?

Wegovy Eligibility with a BMI of 31 You likely qualify, but with a condition. The FDA approval criteria for Wegovy requires: BMI of 30+ (obesity) — ✅ you meet this OR BMI of 27+ with at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol) So at BMI 31, you qualify on BMI alone. Reputable Online Prescribers to Consider Ro Body Comprehensive program with provider visits and ongoing support ro.co Hims & Hers Easy telehealth intake process, licensed providers hims.com / forhers.com Found Focuses specifically on weight management, good ongoing coaching joinfound.com Noom Med Combines behavioral program with medical prescribing noom.com Sequence (now part of WeightWatchers) Insurance navigation help, which can be valuable since Wegovy is expensive joinsequence.com Important Caveats Cost is significant (~$1,300+/month without insurance) A provider will still evaluate your full health history before prescribing Shortage issues have affected availability Always use a legitimate licensed provider, not unregulated sources Would you like more detail on any of these options?

Mentioned in position 5 of 5

Read full answer with sources →
ClaudeSep 10, 2026, 15:14 UTC
Wegovy through telehealth vs my regular doctor: which is faster and cheaper?

Wegovy: Telehealth vs. Regular Doctor Telehealth is almost always faster, and often cheaper for getting started. Telehealth Options (Recommended for Speed) Ro Body – Quick online assessment, often prescribed within 24-48 hours, competitive pricing Hims & Hers – Fast intake process, good for initial consultation Found – Specializes in weight management, knowledgeable providers Sequence (WeightWatchers) – Structured program with coaching support Typical telehealth timeline: 1-3 days to get a prescription Why Telehealth Wins on Speed No waiting weeks for an appointment Async or same-day video consultations Online pharmacy integration Why Your Regular Doctor Might Be Better Insurance coordination – They know your history and can navigate prior authorization more effectively Cheaper long-term – If you have good insurance, your copay may beat telehealth subscription fees Ongoing monitoring – Better for managing side effects with someone who knows you The Real Cost Driver Insurance coverage matters most. Wegovy lists at ~$1,350/month without insurance. With coverage, either route becomes affordable. Bottom line: Start with telehealth for speed, but loop in your regular doctor if you have insurance that covers GLP-1s.

Mentioned in position 4 of 4

Read full answer with sources →

TL;DR

Sequence, found at sequencewiz.org, is a telehealth platform focused on GLP-1 weight loss medications, connecting patients with clinicians who can prescribe drugs like Wegovy, Zepbound, and Ozempic. According to WellRank's latest index, it ranks #8 for Zepbound queries (16% visibility), #13 for Ozempic (13%), and #14 for Wegovy (13%), making it a mid-tier but consistently surfaced brand in AI-generated answers about GLP-1 access. Its 445 AI mentions in the WellRank corpus skew heavily positive, with 326 positive citations and zero mixed or cautious mentions, suggesting AI engines treat it as a credible option in the telehealth weight loss space.

Company Overview

Sequence operates as a telehealth service specializing in connecting patients with licensed clinicians for GLP-1 medication management and obesity care. Its founding date and headquarters are not publicly disclosed. The business model centers on subscription or visit-based care that facilitates prescriptions for branded GLP-1 medications and supports patients through ongoing weight loss treatment.

Product Features

  • Telehealth consultations with clinicians for GLP-1 medication eligibility
  • Prescription facilitation for Wegovy, Zepbound, and Ozempic
  • Ongoing medication management and follow-up care
  • Insurance navigation support for GLP-1 coverage
  • Weight loss program guidance alongside pharmacotherapy

Target Market

Sequence primarily serves adults in the United States seeking access to GLP-1 medications for weight management and obesity treatment, including those who have struggled to obtain prescriptions through traditional in-person care. It appears to focus on patients who are insurance-eligible or navigating prior authorization requirements for branded GLP-1 drugs.

Buyer Personas

  • A middle-aged adult with a BMI qualifying for GLP-1 therapy who wants a faster, more convenient path to a prescription than their primary care provider offers.
  • A health-conscious professional who has researched Wegovy or Zepbound online and is looking for a legitimate telehealth service to begin treatment.
  • A patient who has tried traditional weight loss programs without lasting results and is now exploring pharmacotherapy for the first time.
  • An existing GLP-1 user seeking a telehealth provider for ongoing prescription refills and medication management after losing access to their original prescriber.

Funding & Performance

Funding stage, total capital raised, and valuation are not publicly disclosed. Whether Sequence is venture-backed or bootstrapped has not been confirmed in widely available sources.

Recent Developments

Sequence has been gaining organic traction in AI-generated answers about GLP-1 access, appearing alongside established telehealth weight loss brands in comparisons covered by sources such as Healthline and Doctronic. The platform appears to have benefited from the broader surge in consumer interest in medically supervised weight loss, though specific product launches or partnership announcements are not publicly confirmed.

Competitive Landscape

Sequence competes in a crowded GLP-1 telehealth segment alongside brands that AI engines most often mention in the same answers, including Calibrate, Ro, Hims and Hers, Found, WeightWatchers, Noom Med, and PlushCare. Comparative roundups such as this GLP-1 telehealth provider comparison and For Hers weight loss coverage illustrate how tightly clustered these brands are in AI answer sets. Sequence's relatively strong Zepbound ranking (#8) suggests it has carved out particular visibility around newer GLP-1 entrants, though it lags peers in the compounded GLP-1 category (#39, 2% visibility).

Sequence vs the brands AI recommends alongside it

The real competitive set in Zepbound: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Sequence logo
SequenceThis brand
#10
15.6%
Calibrate logo
Calibrate

251 shared answers

#3
44.4%
Ro logo
Ro

249 shared answers

#1
57.8%
Hims & Hers logo
Hims & Hers

235 shared answers

#2
55.6%
Found logo
Found

199 shared answers

#5
31.1%

Email me when overtakes Sequence

One email the day the ranks flip. Nothing else.

User Sentiment

AI engines cite Sequence in an overwhelmingly positive light, with 326 of 445 WellRank corpus mentions coded as positive and zero cautious or mixed mentions, a sentiment profile that compares favorably to many peers in the space. Community discussions on platforms like Reddit's Wegovy forum and coverage aggregated by health publishers appear to reinforce its reputation as a straightforward, trustworthy option for GLP-1 access. No notable pattern of negative user experiences surfaces in the AI mention data available.

Pricing

Exact pricing is not publicly disclosed in stable, widely verified form. Sequence is generally understood to charge a subscription or membership fee for access to clinician consultations and ongoing medication management, consistent with common telehealth weight loss business models, but specific dollar figures should be confirmed directly at sequencewiz.org.

Sources cited around Sequence

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Sequence weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Sequence? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.